#BEGIN_DRUGCARD DB02844

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
76426-40-9

# ChEBI_ID:
Not Available

# Chemical_Formula:
C18H29N7O3S

# Chemical_IUPAC_Name:
(2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-5-({[(2E)-1,8-diaminooct-2-en-3-yl]sulfanyl}methyl)oxolane-3,4-diol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
S-Adenosyl-1,8-Diamino-3-Thiooctane

# HET_ID:
AAT

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C18H29N7O3S/c19-6-3-1-2-4-11(5-7-20)29-8-12-14(26)15(27)18(28-12)25-10-24-13-16(21)22-9-23-17(13)25/h5,9-10,12,14-15,18,26-27H,1-4,6-8,19-20H2,(H2,21,22,23)/b11-5+/t12-,14-,15+,18+/m0/s1

# InChI_Key:
InChIKey=SUUGLGYBZXSJAA-HRQDUAQYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2844

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
423.533

# Molecular_Weight_Mono:
423.205258519

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1JQ3

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.09

# Predicted_LogS:
-2.8

# Predicted_Water_Solubility:
6.74e-01 g/l

# Primary_Accession_No:
DB02844

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936507

# PubChem_Substance_ID:
46508172

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00386

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NCCCCC\C(SC[C@@H]1O[C@H]([C@H](O)[C@H]1O)N1C=NC2=C1N=CN=C2N)=C/CN

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:32 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE000512

# Drug_Target_1_GenBank_ID_Protein:
4981177

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
speE

# Drug_Target_1_Gene_Sequence:
>891 bp
TCACATCAGTCCGAGTTCTTTCTTCACGAAATTCGGGAGGGCAAAGGAGGCAACGTGGAC
TTCTTCGTTGTAGTACTTCAGTTCTTTGTTGAACTTTCTCACCTTTTCCGGGTCGAAGTC
TTTTATCGGGTCTATTCCCTTGGAGGCGAAAGTGTAGGACCACATGCCGGAGGGATAGGT
GGTCATGAAACCAAGGTAAACCCTTGTAATCGGAAAGACCTTGCTGATCCTCCTGTAGGC
GAGTTTGAACCATCCGATGTCGTAGAACGGATCCTCCGTTTCTGCAGAGAAGACTCCGTC
TTCCTTCAATGCGTCGTAGCAGGCCTGGTAGAACTCCTCGGTGAAGAGGTGCCCGCCCTG
ACCCGCCGTCGGGTCCGTGGAGTCTATGATGATGACGTCGAACTCGTTTTTGAACTTCCT
CACGTATTCGGCACCGTTTGCTATCACGATCTCCGCTCTGGGATCGTCGAAACCACAGGA
GGTCTGTTTCAGATATTTCCTCGCCGCTTCTATGACGAGGCCATCGACCTCGCAGAGAAT
GGCTTTTTCTACGCTATCGTGCTTGAGGACTTCTCTGAGCGTTCCCCCATCTCCACCACC
GATGATGAGCACCTTCTTCGGATTGGGATGAAGGAACATGGGAACGTGTGCGAGCATCTC
GTGGTACATGAACTCGTCTTTCTCTGTTGTCATTGTGATTCCATCGAGTGCGAAGACCAC
ACCGAGATCGGGGTTTTCGAAGATGTCGATCCTCTGTATATCGCTCTGTCCTGAATAAAT
CACGCGGTTCATCTTCATGAAAAGACCCACGTTGTTTCCCGTGTAGTACTCGAAGTACCA
GAGGTGCTGTCTTGGCTGAAGTTCCCTTTCCAGTTCCTTCAACGTTCTCAC

# Drug_Target_1_General_Function:
Involved in spermidine synthesis activity

# Drug_Target_1_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3038

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
34142

# Drug_Target_1_Name:
Spermidine synthase

# Drug_Target_1_Number_of_Residues:
296

# Drug_Target_1_PDB_ID:
1JQ3

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01564	Spermine_synth

# Drug_Target_1_Protein_Sequence:
>Spermidine synthase
MRTLKELERELQPRQHLWYFEYYTGNNVGLFMKMNRVIYSGQSDIQRIDIFENPDLGVVF
ALDGITMTTEKDEFMYHEMLAHVPMFLHPNPKKVLIIGGGDGGTLREVLKHDSVEKAILC
EVDGLVIEAARKYLKQTSCGFDDPRAEIVIANGAEYVRKFKNEFDVIIIDSTDPTAGQGG
HLFTEEFYQACYDALKEDGVFSAETEDPFYDIGWFKLAYRRISKVFPITRVYLGFMTTYP
SGMWSYTFASKGIDPIKDFDPEKVRKFNKELKYYNEEVHVASFALPNFVKKELGLM

# Drug_Target_1_Reaction:
S-adenosylmethioninamine + putrescine = 5'-S-methyl-5'-thioadenosine + spermidine

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the production of spermidine from putrescine and decarboxylated S-adenosylmethionine (dcSAM), which serves as an aminopropyl donor

# Drug_Target_1_SwissProt_ID:
Q9WZC2

# Drug_Target_1_SwissProt_Name:
SPEE_THEMA

# Drug_Target_1_Synonyms:
EC 2.5.1.16
PAPT
Putrescine aminopropyltransferase
SPDSY

# Drug_Target_1_Theoretical_pI:
5.13

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02844
